Paxlovid, the five-day antiviral treatment for covid, may not reduce the risk of covid-related hospitalizations and all-cause deaths in vaccinated older adults, a new study suggests. Paxlovid ...

Paxlovid consists of two different drugs, nirmatrelvir 150mg tablets co-packaged with ritonavir 100mg tablets. Nirmatrelvir 300mg (two tablets) is taken with ritonavir 100mg twice a day for five days.

What do you do? Specifically, what's the role of antivirals? You might have heard about a drug called Paxlovid. Well, Paxlovid is a pill that you take by mouth, as opposed to some other therapies ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research. The study questions the assumption that Paxlovid's ...

THURSDAY, March 6, 2025 (HealthDay News) -- The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all.

Treatment with Paxlovid in older adults did not appear to make a difference in whether or not they were hospitalized because of COVID-19. Over a 9-month time span starting in April 2022 ...

Please provide your email address to receive an email when new articles are posted on . Paxlovid may not decrease the risk for hospitalization or death among older adults who are vaccinated.